Zura Bio Limited - Class A (ZURA) closed at $3.36 on October 23, 2026, down 4.8% from the previous close, on volume of 5,434,890 shares (30-day average 3,397,646).
Data as of October 23, 2026.
23-Oct-2026
Zura Bio to Participate in the Cantor Global Healthcare Conference
Business Wire (Mon, 31-Aug 4:30 PM ET)
Zura Bio Grants Inducement Awards—What Do the New Options Mean for Investors?
Market Chameleon (Mon, 24-Aug 7:45 AM ET)
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Fri, 21-Aug 7:57 PM ET)
Zura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Business Wire (Tue, 11-Aug 7:30 AM ET)
Zura Bio Strengthens Cash Position and Advances Key Phase 2 Trials, Backed by $144 Million Raise
Market Chameleon (Fri, 20-Mar 6:14 AM ET)
Zura Bio’s $125 Million Public Offering Highlights Strategic Growth in Autoimmune Pipeline
Market Chameleon (Wed, 25-Feb 2:32 AM ET)
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
Zura Bio Limited - Class A trades on the NASDAQ stock market under the symbol ZURA.
As of October 23, 2026, ZURA stock price declined to $3.36 with 5,434,890 million shares trading.
ZURA has a beta of -0.39, meaning it tends to be less sensitive to market movements. ZURA has a correlation of 0.00 to the broad based SPY ETF.
ZURA has a market cap of $321.99 million. This is considered a Small Cap stock.
In the last 3 years, ZURA traded as high as $7.44 and as low as $.97.
The top ETF exchange traded funds that ZURA belongs to (by Net Assets): IWM, VXF, IWO, VTWO, FESM.
ZURA has underperformed the market in the last year with a price return of +0.9% while the SPY ETF gained +14.9%. ZURA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -37.8% and -18.6%, respectively, while the SPY returned +1.9% and -1.8%, respectively.
ZURA support price is $3.32 and resistance is $3.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZURA shares will trade within this expected range on the day.
